{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:15:26Z","timestamp":1794251726062,"version":"4.9.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Artificial intelligence has the potential to revolutionize healthcare, yet clinical trials in neurological diseases continue to rely on subjective, semiquantitative and motivation-dependent endpoints for drug development. To overcome this limitation, we collected a digital readout of whole-body movement behavior of patients with Duchenne muscular dystrophy (DMD) (<jats:italic>n<\/jats:italic>\u2009=\u200921) and age-matched controls (<jats:italic>n<\/jats:italic>\u2009=\u200917). Movement behavior was assessed while the participant engaged in everyday activities using a 17-sensor bodysuit during three clinical visits over the course of 12 months. We first defined new movement behavioral fingerprints capable of distinguishing DMD from controls. Then, we used machine learning algorithms that combined the behavioral fingerprints to make cross-sectional and longitudinal disease course predictions, which outperformed predictions derived from currently used clinical assessments. Finally, using Bayesian optimization, we constructed a behavioral biomarker, termed the KineDMD ethomic biomarker, which is derived from daily-life behavioral data and whose value progresses with age in an S-shaped sigmoid curve form. The biomarker developed in this study, derived from digital readouts of daily-life movement behavior, can predict disease progression in patients with muscular dystrophy and can potentially track the response to therapy.<\/jats:p>","DOI":"10.1038\/s41591-022-02045-1","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T17:04:49Z","timestamp":1674147889000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Wearable full-body motion tracking of activities of daily living predicts disease trajectory in Duchenne muscular dystrophy"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1800-1987","authenticated-orcid":false,"given":"Valeria","family":"Ricotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balasundaram","family":"Kadirvelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Selby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Festenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7424-5401","authenticated-orcid":false,"given":"Thomas","family":"Voit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-7207","authenticated-orcid":false,"given":"A. Aldo","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"key":"2045_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41551-018-0305-z","volume":"2","author":"K-H Yu","year":"2018","unstructured":"Yu, K.-H., Beam, A. L. & Kohane, I. S. Artificial intelligence in healthcare. Nat. Biomed. Eng. 2, 719\u2013731 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"2045_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol, E. J. High-performance medicine: the convergence of human and artificial intelligence. Nat. Med. 25, 44\u201356 (2019).","journal-title":"Nat. Med."},{"key":"2045_CR3","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/s41591-018-0213-5","volume":"24","author":"M Komorowski","year":"2018","unstructured":"Komorowski, M., Celi, L. A., Badawi, O., Gordon, A. C. & Faisal, A. A. The artificial intelligence clinician learns optimal treatment strategies for sepsis in intensive care. Nat. Med. 24, 1716\u20131720 (2018).","journal-title":"Nat. Med."},{"key":"2045_CR4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/diagnostics11071275","volume":"11","author":"B-Y Youn","year":"2021","unstructured":"Youn, B.-Y. et al. Digital biomarkers for neuromuscular disorders: a systematic scoping review. Diagnostics (Basel) 11, 1275 (2021).","journal-title":"Diagnostics (Basel)"},{"key":"2045_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrn2258","volume":"9","author":"AA Faisal","year":"2008","unstructured":"Faisal, A. A., Selen, L. P. J. & Wolpert, D. M. Noise in the nervous system. Nat. Rev. Neurosci. 9, 292\u2013303 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"2045_CR6","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","volume":"132","author":"RC Deo","year":"2015","unstructured":"Deo, R. C. Machine learning in medicine. Circulation 132, 1920\u20131930 (2015).","journal-title":"Circulation"},{"key":"2045_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nmeth0609-413","volume":"6","author":"M Reiser","year":"2009","unstructured":"Reiser, M. The ethomics era? Nat. Methods 6, 413\u2013414 (2009).","journal-title":"Nat. Methods"},{"key":"2045_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nmeth.1328","volume":"6","author":"K Branson","year":"2009","unstructured":"Branson, K., Robie, A. A., Bender, J., Perona, P. & Dickinson, M. H. High-throughput ethomics in large groups of Drosophila. Nat. Methods 6, 451\u2013457 (2009).","journal-title":"Nat. Methods"},{"key":"2045_CR9","doi-asserted-by":"publisher","first-page":"e19920","DOI":"10.7554\/eLife.19920","volume":"5","author":"VM Corrales-Carvajal","year":"2016","unstructured":"Corrales-Carvajal, V. M., Faisal, A. A. & Ribeiro, C. Internal states drive nutrient homeostasis by modulating exploration-exploitation trade-off. eLife 5, e19920 (2016).","journal-title":"eLife"},{"key":"2045_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10654-020-00613-8","volume":"35","author":"E Landfeldt","year":"2020","unstructured":"Landfeldt, E. et al. Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis. Eur. J. Epidemiol. 35, 643\u2013653 (2020).","journal-title":"Eur. J. Epidemiol."},{"key":"2045_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.nmd.2010.09.006","volume":"21","author":"Y Ishikawa","year":"2011","unstructured":"Ishikawa, Y. et al. Duchenne muscular dystrophy: survival by cardio-respiratory interventions. Neuromuscul. Disord. 21, 47\u201351 (2011).","journal-title":"Neuromuscul. Disord."},{"key":"2045_CR12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.nmd.2007.03.002","volume":"17","author":"M Eagle","year":"2007","unstructured":"Eagle, M. et al. Managing Duchenne muscular dystrophy\u2014the additive effect of spinal surgery and home nocturnal ventilation in improving survival. Neuromuscul. Disord. 17, 470\u2013475 (2007).","journal-title":"Neuromuscul. Disord."},{"key":"2045_CR13","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1177\/0883073810371004","volume":"25","author":"RT Moxley 3rd","year":"2010","unstructured":"Moxley, R. T. 3rd, Pandya, S., Ciafaloni, E., Fox, D. J. & Campbell, K. Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J. Child Neurol. 25, 1116\u20131129 (2010).","journal-title":"J. Child Neurol."},{"key":"2045_CR14","unstructured":"ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/results?cond=Duchenne+Muscular+Dystrophy&Search=Apply&recrs=b&recrs=a&recrs=f&recrs=d&age_v=&gndr=&type=&rslt= (2022)."},{"key":"2045_CR15","unstructured":"ClinicalTrials.gov. A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03362502 (2022)."},{"key":"2045_CR16","unstructured":"ClinicalTrials.gov. A Randomized, Double-Blind, Placebo-Controlled Study of SRP-9001 (Delandistrogene Moxeparvovec) for Duchenne Muscular Dystrophy (DMD) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03769116 (2022)."},{"key":"2045_CR17","unstructured":"ClinicalTrials.gov. Microdystrophin Gene Transfer Study in Adolescents and Children With DMD (IGNITE DMD) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03368742 (2022)."},{"key":"2045_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1469-8749.2011.03939.x","volume":"53","author":"A Mayhew","year":"2011","unstructured":"Mayhew, A. et al. Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy. Dev. Med. Child Neurol. 53, 535\u2013542 (2011).","journal-title":"Dev. Med. Child Neurol."},{"key":"2045_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.nmd.2010.06.014","volume":"20","author":"E Mazzone","year":"2010","unstructured":"Mazzone, E. et al. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul. Disord. 20, 712\u2013716 (2010).","journal-title":"Neuromuscul. Disord."},{"key":"2045_CR20","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/dmcn.12213","volume":"55","author":"A Mayhew","year":"2013","unstructured":"Mayhew, A. et al. Development of the performance of the upper limb module for Duchenne muscular dystrophy. Dev. Med. Child Neurol. 55, 1038\u20131045 (2013).","journal-title":"Dev. Med. Child Neurol."},{"key":"2045_CR21","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mus.21544","volume":"41","author":"CM McDonald","year":"2010","unstructured":"McDonald, C. M. et al. The 6\u2010minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 41, 500\u2013510 (2010).","journal-title":"Muscle Nerve"},{"key":"2045_CR22","doi-asserted-by":"publisher","first-page":"e52512","DOI":"10.1371\/journal.pone.0052512","volume":"8","author":"ES Mazzone","year":"2013","unstructured":"Mazzone, E. S. et al. 24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. PLoS ONE 8, e52512 (2013).","journal-title":"PLoS ONE"},{"key":"2045_CR23","doi-asserted-by":"publisher","first-page":"e1386","DOI":"10.1212\/WNL.0000000000008939","volume":"94","author":"KJ Naarding","year":"2020","unstructured":"Naarding, K. J. et al. MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy. Neurology 94, e1386\u2013e1394 (2020).","journal-title":"Neurology"},{"key":"2045_CR24","unstructured":"Balke, B. A Simple Field Test for the Assessment of Physical Ftness (Civil Aeromedical Research Institute, 1963)."},{"key":"2045_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/mus.25743","volume":"57","author":"EG Fowler","year":"2018","unstructured":"Fowler, E. G. et al. Longitudinal community walking activity in Duchenne muscular dystrophy. Muscle Nerve 57, 401\u2013406 (2018).","journal-title":"Muscle Nerve"},{"key":"2045_CR26","doi-asserted-by":"crossref","first-page":"P5.6-016","DOI":"10.1212\/WNL.92.15_supplement.P5.6-016","volume":"92","author":"L Lowes","year":"2019","unstructured":"Lowes, L., Miller, N., Iammarino, M., Dugan, M. & Alfano, L. Activity monitoring in neuromuscular disease: successes, challenges, and a path forward (P5. 6-016). Neurology 92, P5.6-016 (2019).","journal-title":"Neurology"},{"key":"2045_CR27","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1016\/j.nmd.2018.06.363","volume":"28","author":"E Henricson","year":"2018","unstructured":"Henricson, E. et al. Duchenne muscular dystrophy\u2014physiotherapy: P.315Stride to height ratio as a new ambulatory outcome measure in Duchenne muscular dystrophy. Neuromuscul. Disord. 28, S125\u2013S126 (2018).","journal-title":"Neuromuscul. Disord."},{"key":"2045_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.gaitpost.2016.05.013","volume":"48","author":"K Heberer","year":"2016","unstructured":"Heberer, K. et al. Hip kinetics during gait are clinically meaningful outcomes in young boys with Duchenne muscular dystrophy. Gait Posture 48, 159\u2013164 (2016).","journal-title":"Gait Posture"},{"key":"2045_CR29","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/mus.24651","volume":"52","author":"JJ Han","year":"2015","unstructured":"Han, J. J. et al. Reachable workspace reflects dynamometer\u2010measured upper extremity strength in facioscapulohumeral muscular dystrophy. Muscle Nerve 52, 948\u2013955 (2015).","journal-title":"Muscle Nerve"},{"key":"2045_CR30","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1016\/j.nmd.2018.06.360","volume":"28","author":"C Lilien","year":"2018","unstructured":"Lilien, C. et al. Factors influencing spontaneous maximal stride speed in individ-ual Duchenne muscular dystrophy boys. Neuromuscul. Disord. 28, S125 (2018).","journal-title":"Neuromuscul. Disord."},{"key":"2045_CR31","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.nmd.2019.06.003","volume":"29","author":"M Haberkamp","year":"2019","unstructured":"Haberkamp, M. et al. European regulators\u2019 views on a wearable-derived performance measurement of ambulation for Duchenne muscular dystrophy regulatory trials. Neuromuscul. Disord. 29, 514\u2013516 (2019).","journal-title":"Neuromuscul. Disord."},{"key":"2045_CR32","doi-asserted-by":"publisher","unstructured":"Lilien, C. et al. Home-based monitor for gait and activity analysis. J. Vis. Exp. (150), https:\/\/doi.org\/10.3791\/59668 (2019).","DOI":"10.3791\/59668"},{"key":"2045_CR33","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/s41591-020-1009-y","volume":"26","author":"W Bai","year":"2020","unstructured":"Bai, W. et al. A population-based phenome-wide association study of cardiac and aortic structure and function. Nat. Med. 26, 1654\u20131662 (2020).","journal-title":"Nat. Med."},{"key":"2045_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41586-019-1799-6","volume":"577","author":"SM McKinney","year":"2020","unstructured":"McKinney, S. M. et al. International evaluation of an AI system for breast cancer screening. Nature 577, 89\u201394 (2020).","journal-title":"Nature"},{"key":"2045_CR35","doi-asserted-by":"publisher","first-page":"e0113999","DOI":"10.1371\/journal.pone.0113999","volume":"10","author":"AM Seferian","year":"2015","unstructured":"Seferian, A. M. et al. Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne muscular dystrophy: an observational multicenter trial. PLoS ONE 10, e0113999 (2015).","journal-title":"PLoS ONE"},{"key":"2045_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.nmd.2019.02.002","volume":"29","author":"V Ricotti","year":"2019","unstructured":"Ricotti, V. et al. Respiratory and upper limb function as outcome measures in ambulant and non-ambulant subjects with Duchenne muscular dystrophy: a prospective multicentre study. Neuromuscul. Disord. 29, 261\u2013268 (2019).","journal-title":"Neuromuscul. Disord."},{"key":"2045_CR37","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1007\/s00415-020-09800-9","volume":"267","author":"J-Y Hogrel","year":"2020","unstructured":"Hogrel, J.-Y. et al. Normalized grip strength is a sensitive outcome measure through all stages of Duchenne muscular dystrophy. J. Neurol. 267, 2022\u20132028 (2020).","journal-title":"J. Neurol."},{"key":"2045_CR38","doi-asserted-by":"publisher","first-page":"e1852","DOI":"10.1212\/WNL.0000000000007319","volume":"92","author":"M Annoussamy","year":"2019","unstructured":"Annoussamy, M. et al. X-linked myotubular myopathy: a prospective international natural history study. Neurology 92, e1852\u2013e1867 (2019).","journal-title":"Neurology"},{"key":"2045_CR39","doi-asserted-by":"publisher","first-page":"e79945","DOI":"10.1371\/journal.pone.0079945","volume":"8","author":"K Lebel","year":"2013","unstructured":"Lebel, K., Boissy, P., Hamel, M. & Duval, C. Inertial measures of motion for clinical biomechanics: comparative assessment of accuracy under controlled conditions\u2014effect of velocity. PLoS ONE 8, e79945 (2013).","journal-title":"PLoS ONE"},{"key":"2045_CR40","doi-asserted-by":"publisher","first-page":"7313","DOI":"10.3390\/s20247313","volume":"20","author":"C Auepanwiriyakul","year":"2020","unstructured":"Auepanwiriyakul, C., Waibel, S., Songa, J., Bentley, P. & Faisal, A. A. Accuracy and acceptability of wearable motion tracking for inpatient monitoring using smartwatches. Sensors (Basel) 20, 7313 (2020).","journal-title":"Sensors (Basel)"},{"key":"2045_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jbiomech.2018.03.031","volume":"73","author":"S Blair","year":"2018","unstructured":"Blair, S., Duthie, G., Robertson, S., Hopkins, W. & Ball, K. Concurrent validation of an inertial measurement system to quantify kicking biomechanics in four football codes. J. Biomech. 73, 24\u201332 (2018).","journal-title":"J. Biomech."},{"key":"2045_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/19346182.2014.905949","volume":"7","author":"EA Gandy","year":"2014","unstructured":"Gandy, E. A., Bondi, A., Hogg, R. & Pigott, T. M. C. A preliminary investigation of the use of inertial sensing technology for the measurement of hip rotation asymmetry in horse riders. Sports Technol. 7, 79\u201388 (2014).","journal-title":"Sports Technol."},{"key":"2045_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/19346182.2009.9648494","volume":"2","author":"A Kr\u00fcger","year":"2009","unstructured":"Kr\u00fcger, A. & Edelmann\u2010Nusser, J. Biomechanical analysis in freestyle snowboarding: application of a full\u2010body inertial measurement system and a bilateral insole measurement system. Sports Technol. 2, 17\u201323 (2009).","journal-title":"Sports Technol."},{"key":"2045_CR44","unstructured":"Xsens Technologies. MVN User Manual https:\/\/www.xsens.com\/hubfs\/Downloads\/usermanual\/MVN_User_Manual.pdf (2022)."},{"key":"2045_CR45","unstructured":"Xsens Technologies. Full 6DOF Human Motion Tracking Using Miniature Inertial Sensors http:\/\/edge.rit.edu\/content\/P10010\/public\/PDF\/MVN_white_paper.pdf (2009)."},{"key":"2045_CR46","unstructured":"Xsens Technologies. Consistent Tracking of Human Motion Using Inertial Sensing https:\/\/www.xsens.com\/blog\/consistent-tracking-of-human-motion-using-inertial-sensing#:~:text=Xsens%20MVN%20is%20an%20easy,algorithms%20and%20bio%20mechanical%20models (2018)."},{"key":"2045_CR47","doi-asserted-by":"crossref","unstructured":"Thomik, A. A., Fenske, S. & Faisal, A. A. Towards sparse coding of natural movements for neuroprosthetics and brain-machine interfaces. In Proc. 7th International IEEE\/EMBS Conference on Neural Engineering (NER) 938\u2013941 (IEEE, 2015).","DOI":"10.1109\/NER.2015.7146780"},{"key":"2045_CR48","unstructured":"Rasmussen, C. E. Gaussian Processes in Machine Learning. In Advanced Lectures on Machine Learning. ML 2003. Lecture Notes in Computer Science (eds. Bousquet, O., von Luxburg, U., R\u00e4tsch, G.) Vol. 3176. (Springer, 2003)."},{"key":"2045_CR49","doi-asserted-by":"publisher","unstructured":"Brochu, E., Cora, V. M. & Freitas, N. D. A tutorial on Bayesian optimization of expensive cost functions, with application to active user modeling and hierarchical reinforcement learning. Preprint at https:\/\/doi.org\/10.48550\/arXiv.1012.2599 (2010).","DOI":"10.48550\/arXiv.1012.2599"},{"key":"2045_CR50","unstructured":"Snoek, J., Larochelle, H. & Adams, R. P. Practical Bayesian optimization of machine learning algorithms. In Advances in Neural Information Processing Systems (eds. Pereira, F., Burges, C. J., Bottou, L., & Weinberger, K. Q.) Vol. 25. 2951\u20132959 (Curran Associates, Inc., 2012)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02045-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02045-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02045-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T16:08:50Z","timestamp":1728749330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02045-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2045"],"URL":"https:\/\/doi.org\/10.1038\/s41591-022-02045-1","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"9 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.R. was a Solid Biosciences employee when the study was conducted. V.R. is cofounder and stockholder of DiNAQOR AG, the products of which are not related to this study. T.V. was a consultant for Antisense Therapeutics, Biophytis, Catabasis, German Centre for Cardiovascular Research, Italfarmaco, Santhera, Sarepta, Servier, Syneos Health and Solid Biosciences. T.V. is a scientific advisory board member and stockholder of Constant Pharmaceuticals and a cofounder and stockholder of DiNAQOR AG. A.A.F. has consulted in the domain of AI for Airbus and Celestial Group. He received research funding paid to his institution from Fresenius Kabi, Shell and Airbus. He received donations given to his institution from Facebook (now Meta), NVIDIA and Microsoft. R.F. has consulted for Pfizer and has received funding from Pfizer but not related to this study. E.M. has received funding as a member of advisory boards for spinal muscular atrophy (SMA) studies for AveXis, Biogen, Ionis Pharmaceuticals, Novartis, Scholar Rock and Roche. E.M. has served as principal investigator for Ionis Pharmaceuticals, Biogen, AveXis and Roche clinical trials and has received funding from Famiglie SMA Italy, Italian Telethon, Biogen and SMA Europe. A.F., R.F., V.R. and T.V. are coinventors of an International Patent Application no. PCT\/EP2020\/077703, \u2018Systems and methods for monitoring the state of a disease using a biomarker\u2019. B.K. and V.S. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}